openPR Logo
Press release

Parkinson’s Disease Market Share, Growth Strategy With Teva Pharmaceutical, Immutep, Novartis, GlaxoSmithKline, Adamas Pharmaceuticals, AbbVie, Acorda Therapeutics, Imugene Limited, Amneal Pharmaceuticals, Osmotica Pharmaceuticals

07-02-2019 01:21 PM CET | Health & Medicine

Press release from: Data Bridge Market Research

/ PR Agency: United States
Parkinson’s Disease Market

Parkinson’s Disease Market

The market research report provides up-to-date parkinson’s disease market information which could assist readers with hands-on information expected to settle on brisk choices anytime during their development venture in the market. The report offers parkinson’s disease market presentation, major overview, goals, market definition, extension, and market size estimation. A definite clarification of market values, potential buyers and the future degree are exhibited in this report. This parkinson’s disease report incorporates driving variables and opportunities prevailing in this parkinson’s disease market, which concentrates the present measurements to broaden the industries quickly. Barriers and limitations of organizations are additionally explained in this report.

This significant rise in market value can increase research development initiatives to launching novel therapies. Global parkinson’s disease market is rising gradually to an estimated value of USD 9.7 Billion by 2026 registering a healthy CAGR of 12.2% in the forecast period of 2019-2026.

To Get The Free Sample Of Report, Click On: https://databridgemarketresearch.com/request-a-sample/?dbmr=global-parkinsons-disease-market

Parkinson’s disease is chronic and progressive neurodegenerative disorders that affects dopamine producing neurons in central nervous system. Parkinson’s disease tends to develops in brain over many years. The patient with Parkinson’s disease experience tremor, slow movement, rigid muscle, impaired posture and balance, loss of automatic movements, slurry speech and others.

According to the Clinical Practice Research Data link summary report 2018, it is identified that there were 145,519 prevalence cases of patient with age 20 and above with Parkinson’s disease in UK seen in the year 2018. The estimation incidence cases were 18,461 in patient aged above 45 or over. This significant rise in patient number acts as a driver for the growth of Parkinson’s disease Market.


Key Developments in the Market:

· In February 2018, Osmotica Pharmaceuticals plc received FDA approval for Osmolex ER (amantadine hydrochloride) which is an extended release tablet indicated for the treatment of parkinson’s disease and drug-induced extrapyramidal reactions in adult patients

· In August 2017, Adamas Pharmaceuticals, Inc. received FDA approval Gocovri (amantadine) extended release tablet for the treatment of dyskinesia in patients with parkinson’s disease receiving levodopa-based therapy, with or without concomitant dopaminergic medications

Access the TOC of the Parkinson’s Disease Market report: https://databridgemarketresearch.com/toc/?dbmr=global-parkinsons-disease-market

Market Drivers

· Increase in prevalence rate of parkinson’s disease worldwide

· Exposure to certain toxin or change in environment may increase the parkinson’s disease

· The launch of new products and research collaboration are the prime strategies to reinforce the market position

· Growing in aging population as it affect most commonly in geriatric population

· Increase in the rate of R&D initiatives is driving parkinson’s disease drug therapeutics market

Market Restraints

· High cost involved in the treatment

· Patent expiry from many companies and introduction of generic drugs is expected to restrain the growth if the market

· Lack of awareness among the patient and physician about parkinson’s disease treatment

Competitive Analysis: Global Parkinson’s Disease Market

Global parkinson’s disease market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of parkinson’s disease market for Global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.

Segmentation: Global Parkinson’s Disease Market

By Type

· Drug-induced parkinsonism

· Vascular parkinsonism

· Normal pressure hydrocephalus (NSA)

· Corticobasal degeneration (CBD)

· Progressive supranuclear palsy (PSP)

· Multiple system atrophy (MSA)

· Idiopathic Parkinson’s

· Others

By Mechanism of Cation type

· Dopamine agonists

· Monoamine oxidase B (MAO-B) inhibitors

· Catechol-O-methyltransferase (COMT) inhibitors

· Adenosine A2 receptor antagonist

By Drug Type

· Amantadine

· Safinamide

· Brivaracetam

· Pimavanserin

· Carbidopa and levodopa

· Rivastigmine tartrate

· Rotigotine

· Ferampanel

· Apomorphine hydrochloride

· Pramipexole

· Others

By Therapy

· Medication

· Deep brain stimulation

· Others

By Route of administration

· Oral

· Parenteral

· Sublingual

· Others

By End Users

· Hospitals

· Homecare

· Specialty Clinics

· Others

By Geography

· North America

o U.S.

o Canada

o Mexico

· South America

o Brazil

o Argentina

o Rest of South America

· Europe

o Germany

o France

o United Kingdom

o Italy

o Spain

o Russia

o Turkey

o Belgium

o Netherlands

o Switzerland

o Rest of Europe

· Asia-Pacific

o Japan

o China

o South Korea

o India

o Australia

o Singapore

o Thailand

o Malaysia

o Indonesia

o Philippines

o Rest of Asia-Pacific

· Middle East & Africa

o South Africa

o Egypt

o Saudi Arabia

o United Arab Emirates

o Israel

o Rest of Middle East & Africa


Want Full Report? Make Inquiries For Your Custom Requirements: https://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-parkinsons-disease-market

Contact Us

Data Bridge Market Research
Toll Free: +1-888-387-2818
Mail: sopan.gedam@databridgemarketresearch.com
https://databridgemarketresearch.com

About Us

Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with an unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. Get Customization and Discount on Report by emailing sopan.gedam@databridgemarketresearch.com . We are content with our glorious 99.9 % client satisfying rate.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Parkinson’s Disease Market Share, Growth Strategy With Teva Pharmaceutical, Immutep, Novartis, GlaxoSmithKline, Adamas Pharmaceuticals, AbbVie, Acorda Therapeutics, Imugene Limited, Amneal Pharmaceuticals, Osmotica Pharmaceuticals here

News-ID: 1794029 • Views: 6504

More Releases from Data Bridge Market Research

Selective Laser Sintering Equipment Market Ongoing Trends and Recent Development …
The Global Selective Laser Sintering Equipment Industry: 2020 Market Report is a professional and in-depth study on the current state of the Selective Laser Sintering Equipment Market. Selective Laser Sintering Equipment market research report makes available the market insights about the business scenario with which better business strategies can be built to thrive in the industry. According to this market report, global market is supposed to witness a moderately higher
Global Fintech Block Chain Market Outlook 2020: By Product, End-User, Geography, …
The Global Fintech Block Chain Industry: 2020 Market Report is a professional and in-depth study on the current state of the Fintech Block Chain Market. The Fintech Block Chain report provides CAGR value fluctuations during the forecast period of 2020-2027 for the market. No stone is left unturned while researching and analyzing data to prepare market research report like this one and the others. It encompasses a methodical investigation of
Botnet Detection Market Global Industry Exhibits Huge Growth by Top Key Players …
The Global Botnet Detection Industry: 2020 Market Report is a professional and in-depth study on the current state of the Botnet Detection Market. This Botnet Detection market research report is a proven and consistent source of information which gives telescopic view of the existing market trends, emerging products, situations and opportunities that drives your business towards the success. Market segmentation studies conducted in this report with respect to product type,
Telecom Service Assurance Market Ongoing Trends and Recent Developments | | Acce …
The Global Telecom Service Assurance Industry: 2020 Market Report is a professional and in-depth study on the current state of the Telecom Service Assurance Market. A team of skilled analysts, statisticians, research experts, enthusiastic forecasters, and economists work painstakingly to structure such a great market research report for the businesses seeking a potential growth. This team is focused on understanding client's businesses and its needs so that the finest market

All 5 Releases


More Releases for Parkinson’s

Parkinson’s Disease Therapeutic Market- Trends, Outlook 2025
Parkinson’s disease (PD) is a chronic disorder characterized by the malfunctioning and death of vital nerve cells in the brain, and can be characterized by tremor, dementia, and depression. Parkinson’s disease progression leads to uncontrolled body movement of the patient. There is no cure presently for parkinson’s disease only treatments options such as medication and surgery to manage the symptoms are available. Parkinson’s disease mainly affects people over 50 and
Parkinson’s disease Therapeutics Parkinson’s disease Therapeutics Market to …
This report studies the global Parkinson's Disease Therapeutics market, analyzes and researches the Parkinson's Disease Therapeutics development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like GSK Novartis Boehringer Ingelheim Teva Pharmaceutical Abbvie ….. Ask for sample copy @ https://www.researchtrades.com/request-sample/1199125 Market segment by Regions/Countries, this report covers United States EU Japan China India Southeast Asia Market segment by Type, Parkinson's Disease Therapeutics can be split into Medications Therapeutics Medical Devices Therapeutics Buy
US Parkinson’s Disease Drug Pipeline Analysis
Parkinson’s disease incidence has been on a rise in the United States in recent years and it most likely to continue rising in the near future. It has been estimated that at least 500,000 people in the United States currently have been diagnosed with this disease. The society pays a significant amount towards treating this disease in the country. It is estimated that the total cost to the nation exceeds
Europe Parkinson’s Disease Drug Pipeline Analysis
Parkinson’s disease incidence has been on a rise in Europe in recent years and it most likely to continue rising in the near future. It has been estimated that currently, more than 1 million in Europe are affected by Parkinson’s disease. This figure is most likely to double by 2030. Among the most common neurodegenerative disease (after Alzheimer’s disease), Parkinson’s is the second most common and it is expected that
Parkinson’s Disease - Heat Map and Analysis
ReportsWorldwide has announced the addition of a new report title Parkinson’s Disease - Heat Map and Analysis to its growing collection of premium market research reports. Parkinson’s disease (PD) is a chronic and progressive neurodegenerative disorder characterized by the progressive loss of muscular control, leading to resting tremor, rigidity, akinesia and postural reflex impairment. PD is an age-related disorder; symptoms typically begin to first appear in patients in their mid-sixties,
New Education Options for Parkinson’s Caregivers
(4/30/2012- Gilbert, Ariz.) When a loved one is diagnosed with Parkinson’s Disease (PD), it becomes clear that Parkinson’s is a life- changing experience for the entire family — particularly for the primary care provider, who is most often a spouse, child or parent. Family caregivers may not think of themselves as a care providers or recognize their new caregiving tasks. As family members begin helping with doctor visits, taking over financial